glp 1 stopping GLP-1 Survey: 37.5% of People Stop GLP-1s after Just 3 Months Safely stopping GLP-1 medication

The UK has approved a once daily Wegovy semaglutide pill for weight loss, marking Europes first oral GLP-1 treatment

Human data (from a meta-analysis of 894 participants) show fenugreek supplementation (0.5 g to 10 g daily over 4 weeks to 6 months) reduces fasting glucose, post-meal glucose, and HbA1c

Explore our recent survey findings showing physicians' growing concerns on GLP-1 overprescribing, long-term sustainability, and the future of obesity treatment.

Book your personalized consultation today.

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

Learn which treatment looks more promising and what patients should know.